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ABSTRACT: The mammalian Slc11a1 and Slc11a2 proteins define a large family of secondary metal
transporters. Slc11a1 and Slc11a2 function as pH-dependent divalent cation transporters that play a critical
role in host defenses against infections and in Fe
2þ homeostasis, respectively. The position and polarity of
individual transmembrane domains (TMD) of Slc11a2 were studied by an epitope tagging method based on
the insertion of small antigenic hemagglutinin A (HA) peptides (YPYDVPDYAS) in predicted intra- or
extracellular loops of the protein. The tagged proteins were expressed in transfected LLC-PK1 kidney cells
and tested for transport activity, and the polarity of inserted tags with respect to the plasma membrane was
determined by immunofluorescence in intact and permeabilized cells. HA epitope tags were inserted at
positions 1, 98, 131, 175, 201, 243, 284, 344, 403, 432, 468, 504, and 561. Insertions at positions 98, 131, 175,
403,and432abrogatedmetaltransportbySlc11a2,whileinsertionsatpositions1,201,243,284,344,468,504,
and 561 resulted in functional proteins. Topology mapping in functional HA-tagged Slc11a2 proteins
indicated that the N-terminus (1), as well as loops delineated by TMD4-5 (201), TMD6-7 (284), and
TMD10-11 (468), and C-terminus (561) are intracellular, while loops separating TMD5-6 (243), TMD7-8
(344), and TMD11-12 (504) are extracellular. These results are compatible with a topology of 12
transmembrane domains, with intracellular amino and carboxy termini. Structural models constructed by
homology threading support this 12TMD topology and show 2-fold structural symmetry in the arrangement
of membrane helices for TM1-5 and TM6-10 (conserved Slc11 hydrophobic core).
The Slc11 family of divalent cation transporters has two
members in mammals, Slc11a1 (also known as Nramp1)
1 and
Slc11a2 (Nramp2, DMT1), which are integral membrane phos-
phoglycoproteins of 90-100 kDa sharing 64% amino acid
sequence identity and 78% similarity (1, 2). Slc11a1 is expressed
in the lysosomal compartment of macrophages and in tertiary
granules of neutrophils and is rapidly recruited to the membrane
ofmicrobe-containingphagosomesformedinthesecells(3,4).At
that site, Slc11a1 functions as a pH-dependent efflux pump for
Fe
2þ and Mn
2þ, restricting the availability of these essential
metals to the enclosed microorganisms and contributing to the
antimicrobial defenses of macrophages (5-7). In mice, naturally
occurring (G169D) or experimentally induced mutations in
Slc11a1 cause susceptibility to a number of infections including
Mycobacterium, Salmonella,a n dLeishmania (2). Likewise, poly-
morphic variants within or in proximity of the human SLC11A1
gene have been found to be associated with increased suscept-
ibility to tuberculosis and leprosy in several populations from
areas of endemic disease (8, 9). The Slc11a2 protein is expressed
at the brush border of the duodenum where it mediates acquisi-
tionofnon-hemedietaryiron.Itisalsoexpressedinthesyntaxin-
13 positive recycling endosome compartment of many cell types,
where it is responsible for the transport of transferrin iron from
the lumen of acidified endosomes into the cytoplasm (10-12).
Differential splicing of 30-exons of the Slc11a2 gene yields two
mRNAs with different 30-end sequences distinguished by the
presence (isoform I) or absence (isoform II) of an iron response
element (IRE). The two isoforms encoded by these mRNAs also
have distinct C-terminal amino acid sequences (1). Although
both isoforms I and II are present at the plasma membrane, they
are expressed in generally different cell types and have distinct
organellar distributions and intracellular trafficking properties.
Isoform II is present in recycling endosomes while isoform I is
present in late endosomes (13). Slc11a2 proteins play a central
role in iron homeostasis, and a loss-of-function mutation
(G185R) causes very severe microcytic anemia in the mk mouse
and in the Belgrade rat (14, 15). In addition, a number of loss-of-
function missense (R416C, G212V, delV114) (16-18) and spli-
cing mutations (18, 19) have been detected in the human
SLC11A2 gene in patients suffering from hypochromic micro-
cytic anemia with serum and liver iron overload.
In transfected mammalian cells, transport studies using iso-
topic
55Fe
2þ and
54Mn
2þ or the metal-sensitive fluorescent dyes
(e.g., calcein and FURA-2) have established that Slc11a1 and
Slc11a2 can transport both metals in a pH-dependent fash-
ion (20). Experiments in Xenopus oocytes have shown that
Slc11a2 is a high-affinity transporter for a number of divalent
cations(inadditiontoFe
2þ andMn
2þ).Transportiselectrogenic
and is caused by proton movement through the transporter
(substrate-dependent and substrate-independent H
þ leak) (21,
22). Sequence analyses show that Slc11 forms a family of metal
transporters highly conserved from bacteria to humans. Func-
tionalstudieson the yeast(Smf1-3), insect (Malvolio), and plant
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(AtNramp1-6) relatives, including yeast complementation
experiments in Smf1-3 knockout strains, indicate that Slc11
proteins share similar function, substrate, and mechanism of
transport (1, 2). Strikingly, even these distantly related Slc11
proteins show a number of highly conserved structural features
which, through functional characterization experiments, have
been shown to play key roles in the mechanism of transport.
These structural features include (a) a number of predicted
membrane spanning domains (TMD), some of which have
amphipathicproperties(23),(b)severalhighlyconservedcharged
amino acid residues within these predicted TMDs, with muta-
tions at several negatively charged positions (D86, E154, D192,
E299) abrogating transport (24), (c) a pair of invariant histidines
(H267, H272) in predicted TMD6 that play a key role in pH
regulation of transport and/or H
þ movement through the
transporter (23, 24), (d) a mutation-sensitive segment at the C-
terminal end of predicted TMD1 (25-27), (e) a highly conserved
sequencemotif(residues384-403),inwhichalterationsabrogate
transport (28), and (f) a cluster of predicted Asn-linked glyco-
sylation sites in an otherwise poorly conserved segment deli-
neated by predicted TMD7 and 8. Finally, a functional fish
Slc11γ transporter lacking predicted TMD11 and 12 has been
described, suggesting that the first ten TMDs constitute the main
functional unit of this family of transporters (29).
High-resolution structural information is ultimately required
not only to understand the mechanism of metal transport by
Slc11 proteins but also to determine how conserved, mutation-
sensitive regions of the transporters coordinate simultaneous
metal and H
þ transport. Determining the secondary structure of
Slc11 proteins is a necessary first step toward this goal. A
combination of multiple sequence alignments, hydropathy pro-
filing, hydrophobic moments, and other predictive methods has
beenusedtoproposethatSlc11proteinsfromanimalscontain12
TMD, while yeast and microbial proteins would contain 11 (23).
Immunofluorescence studies have shown that the amino and
carboxyltermini of mouseSlc11a2 are intracellular (30, 31)w h i l e
the glycosylated loop between predicted TMDs 7 and 8 is
extracytoplasmic in Slc11a1 and Slc11a2 (20). These studies
suggest a model in which the N- and C-termini are intracellular
with an even number of 12 TM domains. Although parallel
topology studies of the Escherichia coli transporter (MntH)
supportthismodel(32),onestudyusingananti-Slc11a1antibody
to inhibit Fe
2þ transport suggests that the N- and C-termini of
Slc11a1 are extracytoplasmic (33).
In the present study, we investigated the topology of the
mammalian Slc11a2 protein, including the number, position,
and orientation of individual transmembrane domains. For this,
we used a hemagglutinin A (HA) epitope-tagging approach in
which the membrane topology of the inserted exofacial epitopes
is established in transport-competent proteins expressed at the
plasma membrane of LLC-PK1 kidney cells. The transmem-
brane topology obtained experimentally was used to test three-
dimensional models of the 10 TMD structural fold that is
conserved among several families of cation-driven transporters.
EXPERIMENTAL PROCEDURES
Materials. Reagent grade chemicals were purchased from
Sigma Chemicals (St. Louis, MO). Geneticin (G418) was ob-
tained from Invitrogen. Monoclonal mouse antibody (HA.11)
directed against the influenza hemagglutin epitope (HA) was
purchased from Covance (Berkeley, CA). Calcein acetoxymethyl
ester (calcein-AM) was purchased from Molecular Probes
(Eugene, OR). Cy3-conjugated goat anti-mouse secondary anti-
bodiesandperoxidase-coupleddonkeyanti-mouseandgoatanti-
rabbit antisera were purchased from Jackson ImmunoResearch
Laboratories(WestGrove,PA).AllrestrictionenzymesandVent
DNA polymerase were obtained from New England Biolabs
(Ipswich, MA).
Plasmids and Site-Directed Mutagenesis. The construc-
tion of the full-length cDNA for murine Slc11a2 isoform II
(-IRE) cloned into the HindIII site of pCB6 (pN2-2myc) was
described elsewhere (24). The construction of Slc11a2 isoform I
(þIRE) full-length cDNA in pCB6 and containing a hemagglu-
tinin (HA) tag in the fourth predicted extracellular loop (pN2-
HAIRE) has been described (13). The Slc11a2 isoform II cDNA
wasexcisedfrompN2-2mycbyHindIIIdigestionandclonedinto
pBluescript KSþ (Stratagene, LaJolla, CA) modified by the
elimination of the SacIa n dXbaI sites from the polylinker to
generate pN2myc-B/S-KO. To improve protein expression in
transfected cells, the full-length Slc11a2 cDNA was modified at
its 50-end by the addition of a consensus GCCACC Kozak
sequence andadditionalEcoRI,MluI,andHindIIIsitestoenable
subsequent cloning into the mammalian expression vector
pCB6 (31). This was done by PCR mutagenesis, using olig-
onucleotide primers EMHK-NT F (50-CAGAATTCACGCG-
TAAGCTTGCCACCATGGTGTTGGATCCTAAAGAAAA-
GATG-30) and N2 501 R (50-GCCAATGACTTCCTGCAT-
GTC-30) and pN2-HAIRE as a template. The 30-end of Slc11a2
in pN2myc-B/S-KO was modified to replace isoform II-specific
30-end sequences with isoform I sequences, using PCR mutagen-
esis with oligonucleotides N2 1051 F (50-ACTCTGGCTGTG-
GACATCTAC-30) and N2-I-CT-HX R (50-CAGTCTCGA-
GAAGCTTTTACTTAATGTTGCCACCGCTGG-30)w i t h
pN2-HAIRE as the template. These modified 50 (N-terminal)
and 30 (C-terminal) fragments of Slc11a2 were then subcloned as
EcoRI/BstEII and SacI/XhoI fragments, respectively, into
pN2myc-B/S-KO to generate the final construct pN2IRE-B/
S-KO.
HA epitopes (YPYDVPDYAS) were inserted in the mouse
Slc11a2(þIRE)protein(13) by recombinant PCR (34)andusing
mutagenic primers listed in Table 1. To facilitate the potential
insertion of additional HA epitopes, a NheI restriction site was
inserted at the 30-end of each HA sequence, accounting for the
additional S residue found at the C-terminus of each HA tag.
pN2-HAIRE was used as a template for all mutagenesis reac-
tions, except for construct 6 for which pN2-2myc was used as a
template. The modified Slc11a2 products were then digested and
subclonedas either EcoRI/BstEII (constructsNT and1), BstEII/
XbaI (constructs 2, 3, 4, and 5), XbaI/SacI (construct 6), or SacI/
XhoI(constructs8,9,10,11,andCT) fragmentsintopN2IRE-B/
S-KO. All constructs were sequenced to verify the absence of
undesiredmutations,priortosubcloningofeachHA-taggedfull-
length Slc11a2 fragment into the HindIII site of pCB6 for
transfection. In the case of constructs 5b, 8b, and 11b, a second
HA epitope was inserted by cloning a short double-stranded
fragment composed of two complementary oligonucleotides into
the engineered NheI sites of the previously inserted HA epitope
sequences.
Cell Culture, Transfection, and Western Blotting. LLC-
PK1 cells (35) were grown in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with10% fetal bovine serum
and 100units/mL penicillin/streptomycin(37C,5%CO2).Cells
were transfected with different Slc11a-HA/pCB6 constructs8424 Biochemistry, Vol. 48, No. 35, 2009 Czachorowski et al.
using lipofectamine 2000 (Invitrogen) as per the manufacturer’s
instructions. Selection for stably transfected clones was carried
out in medium containing G418 (geneticin, 1.4 mg/mL) for 14
days.Individual colonies werethenisolated and expanded.LLC-
PK1 cell clones stably transfected with the various Slc11a-HA/
pCB6 constructs were lysed in buffer (50 mM Tris-HCl, pH 8.0,
137 mM NaCl, 1% NP40, 10% glycerol) supplemented with
protease inhibitors (1 mM phenylmethanesulfonyl fluoride
[PMSF], 1 μM pepstatin, 0.3 μMa p r o t i n i n ,1μM leupeptin).
These whole cell extracts were separated by SDS-PAGE, and
clones exhibiting high levels of Slc11a2-HA protein expression
were identified by immunoblotting, as previously described (31),
and using affinity-purified rabbit polyclonal anti-mouse
Nramp2/DMT1 (1:1000) or a monoclonal mouse anti-HA anti-
body (1:2000). Secondary anti-rabbit and anti-mouse antibodies
conjugated to hoseradish peroxidase were used at 1:20000.
Divalent Metal Transport Assay. Metal transport by
individual tagged Slc11a2-HA proteins expressed in transfected
LLC-PK1 cell clones was carried out using a fluorescence
quenching assay, exactly as we have previously described (31).
Calcein-AMwaspreparedasa500μMstocksolutionindimethyl
sulfoxide (DMSO), while ferrous ammonium sulfate (Fe
2þ)a n d
cobalt chloride (Co
2þ) were prepared as a 2 mM stock in
deionized water. Metal transport in individual LLC-PK1 trans-
fected clones was assessed (initial quenching rates) from fluores-
cence quenching curves (31).
Immunofluorescence. A variation of a cell surface labeling
protocol was used to determine the membrane topology of HA
tags present in individual recombinant Slc11a2 proteins (13).
Stable transfectants were grown to confluency on glass cover-
slips, with empty vector transfected cells serving as a negative
control.To localizethe HA epitopesexpressedonthe cell surface
(nonpermeabilized conditions), cells were incubated with anti-
HA antibody (1:200 dilution) in 2% nonfat milk/DMEM for 2 h
at 37 C prior to fixation with 4% paraformaldehyde in
phosphate-buffered saline (PBS) supplemented with 1 mM
MgCl2 and 0.1 mM CaCl2 (PBSþþ), followed by incubation
withgoatanti-mouserhodamine-conjugatedsecondaryantibody
(1:1000 dilution) in 5% nonfat milk/PBS for 1 h at room
temperature. To localize the HA epitopes expressed intracellu-
larly (permeabilized conditions), cells were fixed with 4% paraf-
ormaldehyde, followed by permeabilization with 0.1% Triton
X-100 for 30 min at room temperature. The cells were then
incubated in primary antibody in 5% nonfat milk/PBS for 1 h at
room temperature before exposure to secondary antibody as
described above. All cells, intact and permeabilized, were in-
cubated in DAPI (40,6-diamidino-2-phenylindole) for 5 min at
room temperature (to stain nuclei) prior to being mounted on
glass microscope slides. Cells were visualized with an Axiovert
200 M epifluorescence microscope using a 63  oil immersion
objective. Digital images were acquired with a Zeiss AxioCam
HRm camera operated with AxioVision 4.3. Images were
cropped, assembled, and labeled using Adobe Photoshop 7.0
and Illustrator 10.0 software.
Quantification of Slc11a2-HA Surface Expression. To
quantify surface expression of extracellular HA tags (detected by
immunofluorescence under nonpermeabilized conditions), we
used a colorimetric assay (36). For this, 2.0 10
4 cells/well (24-
wellplasticplates)wereallowed toreach confluency, followed by
incubation with anti-HA antibody exactly as described for
immunofluorescence (omitting the DAPI staining step). The
secondary antibody was a horseradish peroxidase (HRP)
Table 1: Oligonucleotides Used for Epitope Insertion by Site-Directed Mutagenesis
M1
b V2
NT CA GAA TTC ACG CGT AAG CTT GCC ACC ATG (HA)
c GTG TTG GAT CCT AAA GAA AAG ATG (27)
A98 V99
1 (271)
a GAA TCT GAT TTG CAG TCT GGA GCA (HA) GTG GCT GGA TTT AAG CTG CTC TG (317)
L131 H132
2 (393) TT GGA GTG GTC ACC GGC TTG (HA) CAT CTT GCT GAA GTA TGT CAC CG (416)
L175 S176
3 (524) CA GCC ATC GCC ATC AAT CTG CTG (HA) TCT GCA GGA AGG GTC CCC CTG TG (548)
K201 Y202
4 (603) GTG TTT CTT TTT TTG GAC AAA (HA) TAT GGC TTG CGG AAG CTG GAA GC (626)
P243 S244
5 (729) CTC AGG GGC ATG TTC GTG CCG (HA) TCC TGT CCA GGG TGC CGC ACC (750)
5b (HA) x2
A248 N249
6 (852) C AAG TCT AGA CAG GTG AAT CGG GCC (HA) AAT AAG CAG GAA GTG CGG GAA GC (875)
L344 F345
7 (HA)
N403 L404
8 (1209) GTC ATG GAG GGA TTC CTG AAC (HA) CTA AAA TGG TCG CGC TTT GCC (1230)
8b (HA) x2
V432 E433
9 (1296) C GTC GCT GTC TTC CAG GAT GTG (HA) GAG CAC CTA ACG GGG ATG AAT G (1318)
S468 E469
10 (1404) CA AGC CTG CGG CCA GTG ATG AGT (HA) GAG TTT TCC AAT GGA ATA GGC TGG (1421)
H504 V505
11 (1512) GTT TAT GTC CAG GAG CTA GGG CAT (HA) GTG GCA CTC TAT GTG GTG GCT GC (1532)
11b (HA) x2
K561
CT (1660) GAT ACC AGC GGT GGC AAC ATT AAG (HA) TAA AAG CTT CTC GAG ACT G
(HA)
c YPYDVPDYAS
aNucleotide position in sequence of Slc11a2 isoform I.
bAmino acid residue immediately preceding the site of insertion of the HA epitope.
cHA epitope
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conjugated anti-mouse antiserum (1:4000 dilution), and incuba-
tion was for 1 h at room temperature in 5% nonfat milk/PBS.
The HRP substrate [0.4 mg/mL o-phenylenediamine dihy-
drochloride (OPD); Sigma FAST OPD; 550 μL/well] was used
according to the manufacturer’s instructions. Absorbance read-
ings (492 nm) were taken in an ELISA plate reader (Bio-Rad
Model 450), and background absorbance readings from (i)
nonspecific binding of secondary antibody and (ii) nonspecific
binding of primary antibody to vector-transfected cells were
subtracted for each sample.
Sequence Analyses. Blast analyses using the murine Slc11a2
protein sequence as query were performed to select sequences
encoding Slc11 homologues (Blast score >400, full-length %
identity >45, expect <2e
-110) from species representative of
Unikonta(motileeukaryoticcellswithasingleflagellum),suchas
Amoebozoa and Opisthokonta, comprising Choanozoa
(unicellular eukaryote with a flagellum), Fungi, and Metazoa
(multicellular motile organisms). The nonmetazoan sequences
wereusedas the phylogeneticoutgroup (37).The sequences from
selected model species were retrieved using NCBI’s Entrez life
sciences search engine. Unikonta: Amebozoa (Dictyostelium
discoideum, AAO52395, DdNR2), Opisthokonta: Choanoflagel-
late (Monosiga brevicollis, XP_001750777, MbreNR), Fungi
(Zygomycota, Phycomyces blakesleeanus, PblNR2), and Meta-
zoa: Porifera (Reniera, tropical marine demosponge, ReniNR);
Eumetazoa: Cnidaria (Nematostella vectensis, sea anemone,
XP_001635621,NvecNR)andBilateria:Protostomia:Cuticulata:
arthropoda (Drosophila melanogaster, Fruit fly, NP_524425
DmeNR, Malvolio) and Lophotrozoa, Platyhelminthe
(Schistosoma mansoni, AAS99648, SmNRa) and Mollusca
(Mizuhopecten yessoensis, Giant scallop, BAD99106, MyesNR),
Deuterostomia: Echinodermata (Strongylocentrotus purpuratus,
sea urchin, XP_781841, SpurNRa), Chordata (Ciona intestinalis,
Sea squirt, XP_002127954, CinNR), Vertebrata: Actinopterygii,
Teleost fishes (Pagrus major, Red seabream, AAR83912,
PmaNR, and Danio rerio, Zebra fish, NP_001035460, DreNR)
Sarcopterygii, Tetrapoda, Amphibia (Frogs) Xenopus (Silurana)
tropicalis (NP_001116938, XtrNR2) and Xenopus laevis
(NP_001088008, XlaeNR1), Amniota, Archosauria (Gallus gal-
lus, chicken, ABI24020, GgNR2, and NP_990295.1, GgNR1),
Mammalia(Musmusculus,la bo ra to rymo us e ,P4 9 28 2 ,Mm N R2 ,
P41251, MmNR1). The 18 sequences were aligned using Clus-
talX (38); the multiple sequence alignment was edited manually
using Seaview (39) and displayed with Genedoc.
HomologyModeling.ThemouseSlc11a2sequencewasused
as query to generate the best structural models resembling
templates present in the PDB using a threading approach, which
combines tridimensional fold recognition by sequence alignment
withtemplatecrystalstructuresandmodelstructurerefining(40).
Three complementary suites of programs were used: (a) the
LOcal MEta-Threading-Server (41) that returns the best struc-
ture predictions collected from nine independent threading
algorithms and ranked using a consensus method; i.e., best
models are more frequent and structurally refined using Mode-
ler (42); (b) the I-TASSER server (43), which uses variations of
the threading approach based on sequence profile-profile align-
ments combined to ab initio modeling by iterative implementa-
tion of the Threading ASSEmbly Refinement (TASSER); (c) the
MUSTER server (44) that uses the MUlti-Source ThreadER
(MUSTER) to incorporate weighted information from six
sources to improve fold recognition and that uses also Modeler
for structural refinement. The best models were selected among
those predicted by the three approaches, and candidate models
were checked for acceptable CR root-mean-squared deviation
(rmsd, <6 A ˚ for template with less than 20% sequence identity
with Slc11a2) and consistency between locations modeled for
(Slc11 family specific) functional sites and prior experimental
results of solvent accessibility in situ:M n t HT M D 1A s p
34 and
TMD6 His
211 apparentlyaccessible,and Asn
3 7 ,2 5 0 ,4 0 1inTMD1,
7, and 11, not accessible (27).
RESULTS
Construction of Epitope-Tagged Slc11a2 Mutants. The
multiple sequence alignment presented in Figure 1 shows the
position of the TM domains for the animal members ofthe Slc11
transporter family as predicted by homology threading (27). To
verify this model as well as establish the position and polarity of
individual TMDs, we used an epitope insertion technique pre-
viously utilized to establish the membrane topology of several
independent ABC transporters (34, 45). This method consists of
inserting hemmaglutinin A (HA) epitopes in various extracyto-
plasmic(EC) andintracytoplasmic(IC) loopsdelineatedbypairs
of predicted TMDs, expressing the recombinant proteins in
transfected cells and monitoring the polarity of the engineered
HA tags by immunofluorescence in intact or permeabilized cells
torevealextra-andintracytoplasmicloops.Thisapproachallows
one to obtain topological data in transport-competent proteins
properly expressed at the plasma membrane. Additionally,
certain HA tag insertions causing loss of transport can provide
additional clues on structure-function relationships.
HA epitopes (YPYDVPDYAS) were inserted at both termini
and in each predicted loop (from hydropathy plot (23)) between
pairs of consecutive TMDs (Figures 1 and 2). The insertion
positionsof the HAepitopesweredeliberatelychosen asthe least
conserved regions among Slc11 family members to minimize
possible disruptions on protein function (Figure 1). HA epitopes
were inserted at positions 1 (N terminus; NT construct), 98
(construct1),131(construct2),175(construct3),201(construct4),
243 (construct 5a), 284 (construct 6), 344 (construct 7), 403
(construct 8a), 432 (construct 9), 468 (construct 10), 504
(construct 11a), and 561 (C-terminus, CT construct) (Figure 2).
In addition, two adjacent HA tags were inserted at positions 243
(5b), 403 (8b), and 504 (11b) to increase the immunofluorescence
signal.WeusedSlc11a2isoformIcDNAasthebackboneforHA
tag insertion as it shows higher surface expression and slower
internalization kinetics than isoform II in porcine LLC-PK1
cells (13, 36), facilitating detection of cell surface protein expres-
sion by immunofluorescence.
Expression of Epitope-Tagged Slc11a2 Mutants in
Transfected LLC-PK1 Kidney Cells. All tagged Slc11a2
cDNAs were transfected into LLC-PK1 cells, and the expression
of the resulting HA-tagged Slc11a2 proteins was verified by
immunoblotting. Representative immunoblots using a polyclo-
nal antibody recognizing the N-terminus of Slc11a2 (Figure 3A)
and an anti-HA monoclonal antibody (Figure 3B) are shown for
single clones. Previous studies in these cells have shown that
Slc11a2 is detected as two immunoreactive species of ∼60 and
∼90 kDa, corresponding to core glycosylated and complex
glycosylated forms, respectively (46). Briefly, we could obtain
stable transfectants expressing robust levels of Slc11a2 for
constructs 4-11 as well as for constructs bearing N- and C-
terminiepitopetags.Forconstructs1-3,itwasdifficulttoobtain
stably transfected clones expressing robust levels of Slc11a2,
and in cell clones positive for expression, only low levels of the8426 Biochemistry, Vol. 48, No. 35, 2009 Czachorowski et al.
∼60kDaimmunoreactivebandcouldbedetected(Figure3A).In
addition, expression of constructs 1-3 could only be detected
with the anti-Slc11a2 antiserum and not with the anti-HA
antibody, suggesting that the HA epitope may be unstable or
FIGURE 1: Evolutionary conservation of the hydrophobic core of Slc11a2 (TMD1-10). Multiple sequence alignment of Slc11 homologues
from representative Unikonta species (phylogenetic relationships schematized and inserted at the beginning of the alignment, A, animals,
and V, vertebrates): Amebozoa (DdNR2), Choanoflagellate (MbreNR), Zygomycota (PblNR2) and Metazoa: Porifera (ReniNR) and
Eumetazoa: Cnidaria (NvecNR) and Bilateria: Protostomia, Cuticulata (DmeNR) and Lophotrozoa, (SmNRa and MyesNR), and
Deuterostomia, Echinodermata, (SpurNRa), Chordata, (CinNR), Vertebrata, Teleost fishes (PmaNR and DreNR), Tetrapoda, Amphibia
(XtrNR2and XlaeNR1), Amniota(GgNR2 andGgNR1), andMammalia(MmNR2 andMmNR1). Residueconservationisindicatedwith
threecutofflevelsofidentity(40%,80%,and100%).ThepositionofSlc11a2transmembranedomains(TMD)wasdeducedfromhomology
modeling using three different template structures (2a65, LeuT-Slc6 (53), 3dh4, vSGLT-Slc5, (50) and Mhp1-Slc23 (51), and highlighted
with rainbow color code (TMD1, blue, TMD12, red). The position of the mouse Nramp2/Slc11a2 (MmNR2) protein used for all studies in
this work is the fourth from the bottom of the multiple sequence alignment. The insertion sites for HA epitope tags (triangles) resulting in
transportactive(orange)ortransportinactive(black)Slc11a2proteinsareindicated.Thepositionofcriticalresiduesatwhichmutationsare
known to cause loss of function (D86, G88, E299, and R416) or to impair severely MmNR2 transport activity (E154, G185, D192, Q384,
G394)areindicatedinthesequenceofMmNR2.Theyarecoloredintheprimarysequencerespectivelyinredandmagenta,andtheirposition
is indicated by a tick of the corresponding color under the multiple sequence alignment.Article Biochemistry, Vol. 48, No. 35, 2009 8427
inaccessible for detection in these constructs. These results also
suggest that the HA tag insertion in constructs 1-3 may have a
detrimental effect on protein stability, maturation, and/or pro-
cessing to the ∼90 kDa fully glycosylated and membrane-
expressed isoform.
Functional Analysis of Epitope-Tagged Slc11a2 Mut-
ants in Transfected LLC-PK1 Kidney Cells. To evaluate
possible detrimental effects of the HA epitope tag insertions on
protein function, transport properties of individual Slc11a2
tagged proteins were assessed in corresponding LLC-PK1 trans-
fected cells (Figure 4). Indeed, proper plasma membrane expres-
sion of the protein is required to detect Slc11a2-mediated metal
import in intact cells (24, 47). Divalent metal transport activity
was measured using a fluorescence quenching assay in calcein-
loaded cells (31). The pH-dependent transport (pH 5.5) of two
divalent metals (Fe
2þ and Co
2þ) was tested to assess possible
effects of tag insertion on ion selectivity of Slc11a2 (24). Trans-
port rates were estimated from the slope of initial quenching
curves following addition of metal to the calcein-loaded cells. In
thesestudies,LLC-PK1cellstransfectedwithemptyvectorswere
used as a negative control, while cells expressing wild-type
Slc11a2 were used as a positive control. We noted three pheno-
typic consequences of tag insertion on Slc11a2 function. For
constructs 1-3, HA tag insertion completely abrogated protein
function, with transport rates similar to those detected in the
pCB6-transfectednegativecontrol(nosignificantdifference,p>
0.05). These results indicate that this segment of the protein is
highly mutation sensitive (affecting either transport per se or
targeting of the protein to the cell surface), in agreement with
results previously obtained with point mutants in these re-
gions (25-27). In a second group of constructs, namely, 4,
5(b), 6, 7, 10, and 11(b) as well as NT and CT, the epitope
insertion had no major functional consequence, with transport
rates similar or superior to those detected in the positive control
(7-12-fold stimulation above background). Finally, constructs
8bor9repeatedlyshowedseverelyreducedtransportrates,which
werenotstatisticallydifferent(p>0.05)fromthosemeasuredin
the negative control. No major effect of HA tag insertion on ion
selectivity was detected in any of the constructs that retained
detectable metal transport activity. We next proceeded to deter-
mine the subcellular location (intra- or extracytoplasmic) of HA
epitopes in Slc11a2 variants that retained transport activity. Due
FIGURE 2: Construction of Slc11a2 proteins containing hemagglutinin (HA) epitope tags. The sites for insertion of YPYDVPDYA hemagglu-
tinin(HA)epitopesinindividualSlc11a2proteinsareindicated,alongwiththenumericaldesignationoftheconstruct(NT,1-11,CT).Thesehave
been superimposed on the hydropathy plot of the Slc11a2 protein produced by the TOPPRED software package using a 20-residue long sliding
window (core window, 12 residues; wedge windows, 4 residues). The default parameters suggested for predicting the presence of TMDs in
eukaryotic proteins were used, such as the Kyte-Doolittle cutoff values (lower, 0.6; putative; upper, 1.0; certain). Orange arrowheads indicate
insertion sites that produced functional proteins in which the polarity ofthe tag could be established by immunofluorescence. Black arrowheads
indicateinsertionsitesthatcausedpartialorcompletelossoftransport.Singlearrowheadsrepresentsingleepitopetagswhiledoublearrowheads
(5b,8b,11b)representconstructswithtwoepitopetagsinsertedsidebyside.Boxesatthetopofthegraphindicatethelocationoftheproposed2-
fold structural symmetry in Slc11a2.
FIGURE 3: Expression of HA epitope-tagged Slc11a2 constructs in
LLC-PK1 cells. LLC-PK1 cells were stably transfected with Slc11a2
isoform I cDNA constructs (listed) modified by the addition of
individualordouble(b) HAepitopesandinsertedinthemammalian
expression vector pCB6. Total cell lysates (5 μg per lane) were
prepared, resolved by electrophoresis on a 10% SDS-polyacryla-
mide gel, and analyzed by Western blotting with a polyclonal rabbit
anti-Slc11a2 antibody (panel A) or with the mouse monoclonal anti-
HA epitope antibody 16B12 (panel B). The asterisk indicates that
construct 7 was created by our group in another study (20). The
positions of the molecular mass markers are indicated on the left of
the figure in kDa.8428 Biochemistry, Vol. 48, No. 35, 2009 Czachorowski et al.
tothedetrimentaleffectofthetagsonSlc11a2proteinexpression
andmetaltransportforconstructs1-3,wedidnotpursuefurther
their characterization.
Membrane Polarity of the Inserted HA-Epitope Tags.
Theintra-orextracytoplasmicnatureofHAtagswasdetermined
foreachconstructbyimmunofluorescencewiththeircorrespond-
ing LLC-PK1 transfectants using the anti-HA monoclonal anti-
body (Figure 5). Immunofluorescence was performed in parallel
on intact cells to detect extracytoplasmic tags and in permeabi-
lized cells treated with detergent to detect intracytoplasmic tags.
In all cases, cell nuclei were stained with DAPI to identify the
position of the corresponding cells (Figure 5). LLC-PK1 cells
transfected with empty pCB6 vector were used as negative
controls, and no significant cell-associated fluorescence could
be detected in these cells with the anti-HA antibody under either
nonpermeabilizingorpermeabilizingconditions(Figure5,panels
A-D). In contrast, strong fluorescent signals were observed in
both intact and permeabilized cells for constructs 5b (TMD 5-6
segment, two epitopes), 7 (TMD 7-8 segment), 8b (TMD 8-9
segment), and 11b (TMD 11-12 segment, two epitopes)
(Figure 5: N, P; V, X; Z, AB; AL, AN), suggesting that the
corresponding segments of Slc11a2 are extracytoplasmic. Con-
versely, strong fluorescence signals were obtained only under
permeabilizing conditions for cells transfected with constructs
NT (N-terminus), 4 (HA between TMD 4-5 segment), 6 (TMD
6-7 segment), 9 (TMD 9-10 segment), 10 (TMD 10-11
segment), and CT (C-terminus) (Figure 5: F, H; J, L; R, T;
AH, AJ; AP, AR), suggesting that the corresponding tagged
segments of Slc11a2 are intracytoplasmic. For certain constructs
(5, 8, and 11), the insertion of a single HA tag did not produce a
clear fluorescence signal in transfected cells in any conditions
(data not shown). However, the insertion of a second adjacent
HAtag produced unambiguous immunofluorescence results (5b,
8b,and11b,twoepitopes;Figure5).Foralloftheconstructs,the
polarity of the HA tags was validated by immunofluorescence in
multiple independently transfected cell clones.
Validation of HA-Epitope Localization in SLC11A2.
The topology of inserted HA tags established by immunofluor-
escence was validated by an enzymatic method, which addition-
ally provides a quantitative measure of exofacial tag surface
expression. For this, LLC-PK1 transfectants expressing indivi-
dual HA-tagged Slc11a2 constructs were fixed and incubated
with primary anti-HA antibody with or without prior permea-
bilization with detergent. The cells were then incubated with a
secondary HRP-conjugated antibody, and the amount of bound
secondary antibody was quantified colorimetrically using the
HRP substrate o-phenylenediamine dihydrochloride. Results in
Figure 6 show the amount of surface expression (detected under
nonpermeabilized conditions) of HA-tagged constructs ex-
pressed as a fraction of total protein (detected under permeabi-
lized conditions). LLC-PK1 cells stably transfected with
constructs 5b, 7, 8b, and 11b were found to have a significantly
greater proportion of accessible HA-tagged Slc11a2 at their
surface than constructs NT, 4, 6, 9, 10, and CT (Figure 6). These
results are in agreement with immunofluorescence experiments
and indicate that the tags in constructs 5b, 7, 8b, and 11b are
extracellular while the tags in constructs NT, 4, 6, 9, 10, and CT
are intracellular.
A Three-Dimensional Framework for Slc11a2. Homol-
ogy modeling has recently become an important tool to predict
secondary and tertiary structures of membrane proteins. For
instance, structural models of the human dopamine transporter
DAT were generated using the LeuTAa crystal structure as a
template, and these were then used to predict probable primary
and secondary pharmacological binding sites on the transporter.
Such binding sites were subsequently validated in detailed dock-
ing studies with known DAT ligands (56). In an independent
study, it was noted that the 12 TM helices in the crystal structure
of E. coli Na
þ/H
þ exchanger A (EcNhaA) superimposed strik-
ingly with the pattern of evolutionary conservation of both the
bacterial and human Na
þ/H
þ exchangers. Homology modeling
was then used to assign the position, boundaries, and angulation
of the 12 TM domains in the human homologue NHE1 (∼10%
sequence identity; 14 TMDs in total). This exercise positioned
some key residues and functional sites within a predicted highly
conserved membrane fold in the human protein which were then
validatedexperimentallyinsite-directedmutagenesisstudies(57).
Topologydataobtainedexperimentallywereevaluatedusinga
tridimensional framework derived by sequence threading using
available structures of distantly related proteins. Current num-
bers of protein families (>30% sequence identity) represent a 3-
foldexcesscompared toproteinfolds (<20% sequenceidentity),
and a similar trend was reported for membrane proteins with
high R-helical content (49). Accordingly, despite littleamino acid
sequence similarity, three cation-driven membrane transporters
(Slc23 Mhp1, Slc6 LeuT, and Slc5 vSGLT) exhibit similar
structures,includinganovelfoldforR-helicalintegralmembrane
proteins (50-53). In addition, these structures represent discrete
possible steps in cation-driven transport cycle (open to out, open
toout-occludedbysubstrate,opentoin).Homologymodelingof
Slc11a2 showed excellent superimposition on these apparently
unrelated templates (Figure 7), implying common architectural
features underlying shared mechanistic aspects of membrane
transport. The models that are presented in Figure 7 have been
FIGURE 4: Metal transport activity of HA epitope tagged Slc11a2
proteins expressed in LLC-PK1 cells. Metal-transport activity of
HA-tagged Slc11a2 variants was tested using a fluorescence-quench-
i n ga s s a y .B r i e f l y ,1  10
6 cells were loaded with the metal-sensitive
fluorescent dye calcein-AM, followed by incubation with either
20μMC o
2þ or 20μMF e
2þ in acidic(pH 5.0) buffer and continuous
monitoring of fluorescence quenching over time (2 min) using a
spectrofluorometer (excitation wavelength, 488 nm; emission wave-
length, 517 nm). The slopes of the initial fluorescence quenching
curves were calculated and reflect cation transport activity of indivi-
dual HA constructs. Results are shown as the initial rates of
fluorescence quenching, as described previously (24), with error bars
representing the standard error on the means of three to five
independent experiments. *, one-way ANOVA followed by a Dun-
nett’s posthoc test indicated no significant difference (P >0 . 0 5 )i n
quenchratebetweentheemptyvectorcontrol(pCB6)andconstructs
1-3,8,and9.Furthermore,nosignificantdifference(P=0.95;two-
way ANOVA) was observed in quench rate for the two metals tested
for any of the clones analyzed.Article Biochemistry, Vol. 48, No. 35, 2009 8429
highlighted (bold) in Supporting Information Table 1. Models
were ranked according to their prediction scores, where higher
value increases confidence in the model predicted (taking into
account the respective cutoff scores of each program). A compi-
lation of these results is provided in Supporting Information
Table 1 together withdetails regarding the LOMETSpredictions
FIGURE 5: Detection ofHA epitope-tagged Slc11a2 proteins byimmunofluorescence. LLC-PK1 cells stably transfected witheither empty pCB6
vectororindividualHA-taggedSlc11a2variantswereanalyzedbyimmunofluorescence.AschematicrepresentationofthesiteofHAtaginsertion
inSlc11a2 variantsisshown in the leftpanel.Immunofluorescencewas carried out withthe mouse monoclonalanti-HA epitope antibody16B12
oncellseitheruntreated(intactcells;lefttwocolumns)orpretreatedwith0.1%TritonX-100(permeabilized;righttwocolumns).Cellswerethen
incubated with secondary goat anti-mouse antibody conjugated to rhodamine (Cy3), and images were acquired by epifluorescence microscopy.
The HA epitopes in constructs 5b (M-P), 7 (U-X), 8b (Y-AB), and 11b (AK-AN) were detected in intact and permeabilized cells
(extracytoplasmic), while the HA epitopes in constructs NT (E-H), 4 (I-L), 6 (Q-T), 9 (AC-AF), 10 (AG-AJ), and CT (AO-AR) were detectable
onlyinpermeabilizedcells(intracytoplasmic).Nuclearstaining(DAPI,columns1and3)wasusedasacontroltoascertainthepresenceofcellsin
the microscope field.8430 Biochemistry, Vol. 48, No. 35, 2009 Czachorowski et al.
which are given in Supporting Information Table 2. Similar
results were obtained using different approaches (mGenTHRE-
ADER, GenTHREADER, CBS WWW Server) (data not
shown). Models for the open-to-out form (resembling LeuT
and Mhp1), and for the open-to-in form (vSGLT) were fre-
quently obtained with significant scores. Although the models
obtained with the template LeuT had lower confidence values,
their architecture was highly consistent with those derived from
both Mhp1and vSGLTtemplates. Finally, the models presented
were selected for consistency with additional functional data
published by our group. To evaluate accuracy in modeling the
Slc11a2 fold, we used a representative set of candidate models
thatcomprisedthetopfourcandidatestructuresproducedbythe
program MUSTER, which represent either the LeuT/vSGLT/
Mhp1 fold or the GlpT/MFS fold (Supporting Information
Table 1). These models were checked for acceptable CR root-
mean-squared deviation (rmsd) using three different programs
that perform pairwise structure alignment and provide a global
rmsd. Each model was aligned both with its respective template
and with a fourth template that also fitsthe LeuT/vSGLT/Mhp1
fold (BetP). The results presented in Supporting Information
Table 3 demonstrate excellent superposition of each model
structure with its respective template and show that models
representing the LeuT fold superimpose better on the BetP
template than a MFS model. Notably, the most conserved
elements of the Slc11 hydrophobic core (TMD1, 3, 6, and 8;
Figure 1) correspond to TMDs that play key roles in the cation-
driven membrane transport mechanism (50-53) (Figure 7).
TheSlc11a2tridimensionalmodelsderivedfromMhp1,LeuT,
and SGLT were used to locate residues at which naturally
occurring and experimentally induced point mutations abrogate
SLC11A2 transport activity in mice and humans. These muta-
tions were found to affect symmetric elements situated in the
same region of the predicted fold: three map to long TMD3
(E154) and TMD8 (Q384, G394), and the mutations causing
anemia in mammals affect the adjacent TMD4 and 9 (G185,
R416, Supporting Information Figure 1). Such structure-func-
tion relationships support the structural model we propose for
Slc11a2, including a long and oblique arrangement for TMD3
and 8 (Figure 7 and Supporting Information Figure 2). Addi-
tional mutations detrimental for Slc11a2 affect other parts of the
molecule that are predicted to be mobile during the transport
cycle (respectively TMD1 and 7 and TMD2 and 5, Supporting
Information Figures 1 and 2). The tridimensional localization of
criticalSlc11a2mutationsprovidescircumstantialsupportforthe
proposed structural model. Thus, our experimental results with
inserted HA tags in intact cells, including their effects on
transport, can be discussed, taking into consideration this
structural and functional framework.
DISCUSSION
Wehaveusedepitopetaggingtomapthepositionandpolarity
of individual TMD of the Slc11a2 metal transporter. This
approach consists of inserting HA tags at sites showingrelatively
low sequence conservation and delineating TMD segments
predictedbyhydropathyprofilingandothercomputationaltools
(Figures 1 and 2). The recombinant, HA-tagged proteins are
FIGURE 6: Detection of HA epitope-tagged proteins by surface
labeling. Stably transfected LLC-PK1 cells were incubated with
anti-HA antibody with or without prior detergent (Triton X-100)
permeabilization, followed by incubation with a horseradish perox-
idase (HRP)-coupled secondary antibody. The amount of bound
secondary antibody was determined by a colorimetric assay using
o-phenylenediamine dihydrochloride (measured at 492 nm). The
presence of Slc11a2-HA expressed at the cell surface (in intact cells)
is shown as a fraction of total protein expression (in permeabilized
cells) normalized for nonspecific binding of primary and secondary
antibodies in nontransfected LLC-PK1 cells. Error bars represent
standarderrorsofthemeansoftwoindependentexperimentscarried
out in duplicate. *, one-way ANOVA followed by a Dunnett’s
posthoc test indicated a significant difference (P < 0.01) in cell
surface fluorescence between cells transfected with the empty vector
control (pCB6) and constructs 5b, 7, 8b, and 11b.
FIGURE 7: Position of HA epitope insertion sites on the predicted
structural model of Slc11a2. Slc11a2 models were deduced from
homology threading and structure refining based on the crystal
structures of LeuT (top) and vSGLT (bottom). These may represent
discretestepsinthetranslocationcycle(opentooutside/occludedand
open to inside, respectively) of a structural fold shared by different
families(e.g.,Slc5,6,and23).Theviewispresentedfromtheexternal
surface (outside). For clarity, the predicted 10 TMD forming the
hydrophobic core of Slc11a2 has been split at site 5 to present the
N- and C- terminal halves juxtaposed horizontally and comprising
respectively TMD1-5 (blue to green) and TMD6-10 (green to
orange). The Slc11-specific functional motifs Asp-Pro-Gly and
Met-Pro-His (27) are highlighted in red and magenta, and their
respective locations between TMD1a/b and TM6a/b are indicated
in the LeuT model (top). The side chains of the amino acids flanking
each insertion site (numbered according to the preceding TMD) are
highlightedinblack.Comparisonofthetopandbottompanelsshows
possible movements thatmay facilitatesubstrate uptake(N-domain,
TMDs1,2,and5,andC-domain,TMDs6,7,and10).Detailsonthe
modelspresentedinFigure7areprovidedinSupportingInformation
Tables 1 and 3.Article Biochemistry, Vol. 48, No. 35, 2009 8431
stably expressed and tested functionally in mammalian cells,
where the polarity of the tag is established by immunofluores-
cence (Figure 5) in intact (extracytoplasmic) vs permeabilized
cells (intracytoplasmic). The experimental results are then eval-
uated using candidate tridimensional models obtained by se-
quencethreading using available structures inthe PDBdatabase.
This approach provides several advantages over mapping tech-
niques using truncated proteins fused to indicator genes and
proteins (32, 48). Indeed, topology data obtained by epitope
mapping are withfunctional proteins that areproperly processed
and inserted in the membrane of intact cells in a transport-
competentstate.Bythesametoken,topologydataobtainedfrom
HA-tagged proteins showing altered transport function must be
interpreted with great caution. Analyses of sequence threading
and motif conservation are useful for this purpose; for instance,
tag insertionsimpairing Slc11a2 activity werefound mostlyin(a)
shortloopsconnectingconservedTMDs(constructs1,3,8b,and9),
(b) the group of five positive charges that are conserved in the 15
residuestretchspanningtheloopbetweenTM8-9,and(c)theN-
end of TMD9 which may contain a topogenic (positive-inside)
signal. Thus, epitope insertions that impair transport activity
may point to protein segments that are essential for proper
structure, membrane arrangement, and function of the proteins
and that may be studied by further mutagenesis.
Constructs NT, 4, 5b, 6, 7, 10, 11b, and CT were transport
active and showed unambiguous polarity in immunofluorores-
cence studies being either intracytoplasmic (NT, 4, 6, 10, CT), or
extracytoplasmic (5b, 7, 11b). This demonstrates that the
N-terminus,theC-terminus,andtheproteinsegmentsseparating
TM4-5, TM6-7, and TM10-11 are intracytoplasmic. On the
other hand, the segments separating TM5-6, TM7-8, and
TM11-12canbeunambiguouslyassignedasextracellular.These
results are in agreement with structural models deduced from
sequence profiling and modeling (Figures 1 and 2) but also with
topology data obtained for the distant bacterial Slc11 relative
MntH (32). Genetic fusions of cytoplasmic or periplasmic
reporter proteins at different locations in MntH suggested that
loops 1/2, 5/6, 7/8, and 9/10 and the C-terminus are periplasmic
while loops 2/3, 6/7, 8/9, and 10/11 are cytoplasmic. Also, both
the C-terminus and the segment separating TMD7 and 8 were
shown to be periplasmic in transport-active MntH. These and
additionaldatasuggestedan11TMDtopologymodel,wherethe
MntH N-terminus is cytoplasmic and the C-terminus periplas-
mic,whichwasconsistentwithcomputer-basedpredictionsbased
on hydrophobicity, secondary structure propensity, conserva-
tion, and charge density (32).
On the other hand, no topology data could be obtained for
Slc11a2 protein segments delineated by the TM1-2, TM2-3,
and TM3-4 intervals and represented by HA tag insertions in
constructs 1-3. For these constructs, we were unable to isolate
stable LLC-PK1 transfectants expressing high levels of the
corresponding proteins despite several attempts. Positive clones
onlyshowed low level expression ofa proteinisoform(∼60 kDa)
that corresponds to the immature form of Slc11a2. We interpret
this result as epitope insertion in this portion of the protein
causing improper maturation and processing of the protein
(retention in the endoplasmic reticulum), preventing functional
insertion in the membrane as determined by the absence of an
immunofluorescence signal in transfected cells (data not shown)
and ultimately leading to absence of detectable transport. The
mutation-sensitive nature of this region of Slc11a2 has been
previously noted in parallel mutagenesis experiments (25).
Complementation studies in yeast Smf mutants and electrophy-
siological measurements in Xenopus oocytes showed that the
highly conserved C-terminal portionof predicted TMD1 and the
N-terminal portionof predicted TMD2 are critical for transport.
These studies established the importance of several residues in
substrate specificity (including G119, D124, and Q126) and
established a critical role for the G88 residue found in the
invariantDPGNmotifinthisregion(25,28).Finally,theparallel
mutational studies of positions D93 and Q95 and of the DPGN
motif from the MntH bacterial relative have led to the proposal
that this region of TM1-TM2 may form part of a metal binding
siteintheprotein(26,27,54).TheLeuTstructuralmodel(52,53)
suggests a pseudo-2-fold symmetry, in which TMDs 1 and 6
contain membrane spanning discontinuous helices involved in
substrate recognition and ion binding (Figure 7). Such a critical
role for TMD1 could help to explain the loss of function
mutationofSlc11a2construct1,whichbearsanHAtaginsertion
immediatelyC-terminaltoTMD1.Likewise,thecrystalstructure
of LeuT reveals substantial secondary structure in the hydro-
philic loops between TMDs 2-4 and 7-8, loops implicated in
conformational changes during substrate transport (52, 53).
Therefore, it is tempting to speculate that disruption of such
short R-helices (possibly conserved in Slc11a2) may also explain
the loss of protein stability, maturation, and/or transport noted
for constructs 2 and 3 bearing HA epitopes in these segments.
Constructs8b(insertioninTM8-9segment,position403) and
9 (insertion in TM9-10 segment, position 432) gave ambiguous
results that warrant additional discussion. In transfected LLC-
PK1 cells,theseepitopes wereaccessibletothe anti-HA antibody
and could be mapped to the extracytoplasmic and intracytoplas-
mic face of the membrane, respectively. However, this localiza-
tiondoesnotagreeeitherwiththetopologicalmodelproposedby
hydropathy profiling (Figures 1 and 2) and that is supported by
topologymapping inother functionalHA taggedconstructs, nor
with the proposed membrane structure of the distant bacterial
MntHrelative(27,32),norwiththestructuralmodelobtainedby
threading and homology mapping (Figure 7 and Supporting
Information Figures 1 and2). Interestingly, the corresponding
Slc11a2 constructs 8b and 9 showed considerably reduced
transport activity, indicating that the tag insertion disrupted
one or more structural and/or functional properties of the two
variants. Therefore, we cannot exclude the possibility that tag
insertion in these constructs disrupted normal topology or
membrane insertion of the proteins leading to (a) reduced
transport activity and (b) aberrant exposure of the HA epitope
and erroneous associated topology data. Finally, hydropathy
predictions used to derive secondary structure models (Figure 2)
are largely based on the presumption that most TMDs lie
perpendicularly to the plane of the membrane and consist of
approximately19or20aminoacids.Thisassumptionmaynotbe
valid for all TMDs. TMDs 3 and 8 in the transporters LeuT and
Mhp1 and their counterparts TMDs 4 and 9 in SGLT consist of
30 or more amino acids. They span the membrane at oblique
angles and appear to tilt around a central axis parallel to the
membrane plane, suggesting that their extremities may alterna-
tively be exposed to the membrane hydrophobic core and/or be
engaged in interhelical contacts during transport (50, 51, 53)-
(Supporting Information Figure 2). Any epitope insertion near
the boundaries of such long TMD would obviously compromise
topology and function. Additional epitope mapping experiments
with other epitope tags inserted in neighboring positions will be
required to formally test this hypothesis.8432 Biochemistry, Vol. 48, No. 35, 2009 Czachorowski et al.
Regarding HA tag 8b, such a double tag could, on the one
hand, weaken the topogenic signal that precedes TMD9 by
dissipating the net positive charge of this hydrophilic segment
and preventing correct positioning relative to the translocon
machinery and the cytoplasmic side of the membrane. On the
other hand, this effect might be amplified by the peculiar
conformation of TMD8, which is modeled forming an angle
close to 45 deg with the membrane plane and likely interacting
with other helices (Figure 7). Therefore, HA tag insertion
immediately downstream of N403 (in construct 8b) may indeed
be detrimental to function. This fourth predicted intracellular
loop of Slc11a2 (targeted in construct 8b) follows a segment
highly conserved among Slc11 orthologues, including a muta-
tion-sensitiveandhighlyconserved20aminoacidsequencemotif
(positions 384-403). This conserved sequence motif shows that
many invariant residues and mutations at several of these sites
significantly reduce or completely abrogate transport (26, 28).
Likewise,theinsertionofanHAepitopetaginthecorresponding
segment of the yeast orthologue SMF1 also caused a loss of
function (55). But whether this highly conserved sequence motif
forms a membrane-reentrant loop following TMD8 or is instead
integral to a longer TMD8 as currently suggested by homology
modeling (Figure 7) remains to be clarified.
The results yielded by the apparently symmetric constructs 4
and 9 were somewhat unexpected given the levels of sequence
conservation observed at the corresponding sites. Modification
of the well-conserved loop separating TM4-5 did not alter
Slc11a2 functional expression, providing unambiguous data in
a region that had not been previously probed in any Slc11
members. In contrast, insertion of the HA tag in the moderately
conserved loop separating TM9-10 may have impaired mem-
brane insertion of TMD9. This TMD is short comparatively to
others, and it has a positively charged amino end. Insertion of
two negative charges(from the HA tag) closetothe carboxyl end
of TMD9 may further reduce the overall hydrophobicity of that
TMD, resulting in less effective membrane partitioning and
preventing proper overall membrane insertion. Also, based on
the role in external gating of the translocation pathway that was
reported for TMD10 (Figure 7, C-repeat, compare the LeuT and
vSGLTconformations),anotherpossible explanation isthat HA
tag insertion at site 9 may impede a conformational change in
Slc11a2 that may be critical for transport function.
We have also used the sequence of constructs 1, 2, 3, 7, 8b, 9,
and10asqueriesforthreadingandhomologymodeling(datanot
shown). These analyses showed that epitope tagging at sites
experimentally observed to severely affect protein function had a
marked effect on homology modeling (e.g., much lower score
prediction compared to wild-type Nramp2 for construct 1 <
construct 8b < construct 2 ∼ construct 9). These results confirm
that epitope insertions at these sites may have functional con-
sequences on membrane insertion and transport activity of the
corresponding Slc11a2 variants, and therefore topology results
withtheseconstructs(namely,8b and 9) mustbeinterpretedwith
caution.
Finally, the structural model we propose for Slc11a2 (and
other members of the Slc11 family) only emcompasses 10 of the
12 TM domains of the protein. The core 10 TM domains
constitute the functional unit of this family of transporters.
TM domains 1-10 (a) are present in all Slc11 relatives and
(b) show the highest degree of similarity across relatives, includ-
ing the presence of highly conserved and functionally critical
charged residues (16). Although they all function by the same
H
þ-dependent mechanism and display similar substrate specifi-
city and kinetic parameters, most microbial relatives (bacteria,
yeast) have an additional 11th TM, while the higher eukaryote
transporters (including Nramp2/Slc11a2) contain 12 TMs. The
role of the 11th and 12th TMs and additional C-terminal
sequences in the mechanism or regulation of transport is not
fully understood. One can speculate that these TM domains may
(a) contribute additional functional determinants involved in
regulation of transport, (b) provide docking sites for homo- or
heterodimerization of the transporter or interaction with other
proteins or other membrane constituents, or (c) provide structural
determinants for stability and/or targeting to specific membrane
microdomains. With respect to the latter point, we have pre-
viouslyshownthatseveralsequencedeterminantsdownstreamof
TM12 at the C-terminus play an important role in targeting
Slc11a1 and Slc11a2 to different endomembrane compartments
and recycling from the plasma membrane via recycling endo-
somes (6, 29, 37).
Together, our results on Slc11a2 transmembrane topology
have not only contributed to validate the structural model
obtained by homology threading and modeling but additionally
provide a structural frameworkfor structure-function studies in
this family of transporters.
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SUPPORTING INFORMATION AVAILABLE
A description of the different conformations of Slc11a2
basedonhomology modeling,includingtheprojectedposition
of critical residues known to be essential for transport. This
material is available free of charge via the Internet at http://
pubs.acs.org.
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